chemo-io, io-io, or io-mono: which is correct for lung cancer?
Published 4 years ago • 158 plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
7:21
second- & third-line options after chemotherapy or i/o
-
10:43
chemo i-o in frontline mnsclc: pd-l1 tps 1%-49%
-
4:44
nsclc: treating progression after chemo and i-o
-
5:30
chemo i-o in frontline mnsclc: pd-l1 tps greater than 50%
-
7:35
i-o therapy versus surgery or chemotherapy in nsclc
-
6:37
surgical perspective on neoadjuvant io for resectable stage iii nsclc
-
3:02
should patients with lung cancer continue io after completing 2 years of io?
-
4:00
chemotherapy and immunotherapy: to combine or not to combine?
-
1:28
comparing io/tki and tki monotherapy for kidney cancer
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
4:07
chemotherapy with i-o therapy in egfr- or alk-mutated nsclc
-
7:13
i/o chemotherapy in treatment-naïve es-sclc
-
30:31
lung cancer immunotherapy with dr. leena gandhi
-
7:24
debate: surgery for stage iiia patients with lung cancer? - no
-
6:40
chemotherapy/immunotherapy combinations in lung cancer
-
2:31
io-chemo and io-radio options for cancer treatment
-
1:45
real-world outcomes of mrcc in the current io & tki era
-
1:52
is adjuvant immunotherapy necessary in non-small cell lung cancer?
-
4:13
lung cancer: early diagnosis, treatment